About | Free Trial

Last Update

2016-07-07T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Paul McKenzie?

Dr. Paul McKenzie F.

Executive Vice President, Pharmaceutical Operations and Technology

Biogen Idec Inc.

Direct Phone: (617) ***-****       

Email: p***@***.com

Biogen Idec Inc.

225 Binney Street

Cambridge, Massachusetts 02142

United States

Company Description

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one ... more

Find other employees at this company (10,196)

Background Information

Employment History

Vice President of Research and Development for Ethicon Business

JJ's Restaurant

Various Research and Development and Manufacturing Positions

Bristol-Myers Squibb Company

Various Research and Development and Manufacturing Positions

Merck & Co. , Inc.

Vice President

Johnson & Johnson

Affiliations

Advisory Board Member
American Institute of Chemical Engineers

Member of the Board of Trustees
Illinois Institute of Technology

Member of Leadership Teams
GPSG

Executive Director of Public Relations
The International Society for Pharmaceutical Engineering Inc

Education

B.S.
Chemical Engineering
University of Pennsylvania

Ph.D.
Chemical Engineering
Carnegie Mellon University

degrees
chemical engineering

Web References (107 Total References)


...

www.sec.gov [cached]

0001677903 McKenzie Paul BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142 1 EVP Pharmaceutical Oper & Tech


...

www.sec.gov [cached]

0001677903 McKenzie Paul BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142 1 EVP Pharmaceutical Oper & Tech


Biogen names McKenzie EVP pharmaceutical operations, technology - Drug Store News

www.drugstorenews.com [cached]

CAMBRIDGE, Mass. - Biogen on Thursday announced named Paul McKenzie as its EVP pharmaceutical operations and technology, effective July 1. McKenzie, who was previously the company's SVP global biologics manufacturing and technical operations, will head the company's asset management, technical development, supply chain operations, global manufacturing, quality and engineering. "With his extensive technical and development expertise, we believe Paul is ideally suited to lead the next phase of growth across Biogen's development and manufacturing operations," Biogen CEO George Scangos said.

...
McKenzie, who will also oversee the construction and operations of the company's biologics manufacturing facility in Solothurn, Switzerland, joined Biogen from Johnson & Johnson in February. He had most recently been J&J's VP research and development for its Ethicon business, having previously led manufacturing and technical operations for internal and external manufacturing of Janssen's pharmaceutical portfolio. "This is an exciting time to be at Biogen, and I am honored to take the reins of pharmaceutical operations and technology from John Cox, who has been instrumental in creating one of the best teams in the industry and driving leading-edge innovation and operations for our clinical and commercial portfolio," McKenzie said.


Biogen Names Paul McKenzie Executive Vice President, Pharmaceutical Operations & Technology | Business Wire

feeds.businesswire.com [cached]

Biogen Names Paul McKenzie Executive Vice President, Pharmaceutical Operations & Technology

McKenzie to lead technical development and global manufacturing supply for clinical and commercial portfolio
June 21, 2016 11:00 AM Eastern Daylight Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) announced today the appointment of Paul McKenzie, Ph.D., as executive vice president, Pharmaceutical Operations & Technology, effective July 1, 2016. He will report to George A. Scangos, Ph.D., chief executive officer, and will be a member of the Biogen management team. Dr. McKenzie was promoted from his previous position as senior vice president of Global Biologics Manufacturing and Technical Operations.
Dr. McKenzie will lead the organization responsible for asset management, technical development, global manufacturing , supply chain operations, quality, and engineering . He will also oversee construction and operation of Biogen's advanced biologics manufacturing facility in Solothurn, Switzerland. He replaces John Cox, who last month was named chief executive officer of a new Biogen spin-off company dedicated to advancing treatments for hemophilia.
" With his extensive technical and development expertise, we believe Paul is ideally suited to lead the next phase of growth across Biogen's development and manufacturing operations," said Dr. Scangos.
...
Dr. McKenzie joined Biogen in February from Johnson & Johnson, where he held a variety of leadership roles, most recently as vice president of R&D for J&J's Ethicon business. Prior to that role, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen's pharmaceutical portfolio. He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization. Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.
" This is an exciting time to be at Biogen, and I am honored to take the reins of pharmaceutical operations and technology from John Cox, who has been instrumental in creating one of the best teams in the industry and driving leading-edge innovation and operations for our clinical and commercial portfolio," said Dr. McKenzie.
...
Dr. McKenzie graduated from the University of Pennsylvania and received his doctorate in chemical engineering from Carnegie Mellon University.


Biogen Names Paul McKenzie Executive Vice President, Pharmaceutical Operations & Technology | Business Wire

feeds.businesswire.com [cached]

Biogen Names Paul McKenzie Executive Vice President, Pharmaceutical Operations & Technology

McKenzie to lead technical development and global manufacturing supply for clinical and commercial portfolio
June 21, 2016 11:00 AM Eastern Daylight Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ: BIIB) announced today the appointment of Paul McKenzie, Ph.D., as executive vice president, Pharmaceutical Operations & Technology, effective July 1, 2016. He will report to George A. Scangos, Ph.D., chief executive officer, and will be a member of the Biogen management team. Dr. McKenzie was promoted from his previous position as senior vice president of Global Biologics Manufacturing and Technical Operations.
Dr. McKenzie will lead the organization responsible for asset management, technical development, global manufacturing , supply chain operations, quality, and engineering . He will also oversee construction and operation of Biogen's advanced biologics manufacturing facility in Solothurn, Switzerland. He replaces John Cox, who last month was named chief executive officer of a new Biogen spin-off company dedicated to advancing treatments for hemophilia.
" With his extensive technical and development expertise, we believe Paul is ideally suited to lead the next phase of growth across Biogen's development and manufacturing operations," said Dr. Scangos.
...
Dr. McKenzie joined Biogen in February from Johnson & Johnson, where he held a variety of leadership roles, most recently as vice president of R&D for J&J's Ethicon business. Prior to that role, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen's pharmaceutical portfolio. He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization. Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.
" This is an exciting time to be at Biogen, and I am honored to take the reins of pharmaceutical operations and technology from John Cox, who has been instrumental in creating one of the best teams in the industry and driving leading-edge innovation and operations for our clinical and commercial portfolio," said Dr. McKenzie.
...
Dr. McKenzie graduated from the University of Pennsylvania and received his doctorate in chemical engineering from Carnegie Mellon University.

Similar Profiles

Other People with this Name

Other people with the name McKenzie

Shelton McKenzie
Howard University Hospital

Rob McKenzie
Clean Cut Media Ltd

Niels McKenzie
Telford BESST

Ryan McKenzie
Indiana Zeta Alumni Corporation

Richard McKenzie
Ryan Direct Group Limited

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory